60 Degrees Pharmaceuticals, Inc. (SXTP)
60 Degrees Pharmaceuticals will go public soon. The estimated IPO date is June 9, 2023.
IPO Price Range
$4.30 - $6.30
Shares Offered
1,415,095
Deal Size
$7.50M
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 |
|---|---|---|
| Revenue | 6.35 | 2.55 |
| Revenue Growth (YoY) | 149.18% | - |
| Cost of Revenue | 0.85 | 0.7 |
| Gross Profit | 5.5 | 1.85 |
| Selling, General & Admin | 1.12 | 1.46 |
| Research & Development | 5.51 | 0.81 |
| Operating Expenses | 6.63 | 2.26 |
| Operating Income | -1.12 | -0.42 |
| Interest Expense / Income | 3.14 | 2.63 |
| Pretax Income | -4.25 | -3.03 |
| Income Tax | 0 | 0 |
| Net Income | -4.26 | -3.05 |
| Net Income Common | -4.25 | -3.03 |
| Gross Margin | 86.61% | 72.43% |
| Operating Margin | -17.69% | -16.40% |
| Profit Margin | -66.93% | -119.00% |
| Free Cash Flow Margin | -10.77% | -9.35% |
| EBITDA | -0.45 | 0.04 |
| EBITDA Margin | -7.05% | 1.39% |
| Depreciation & Amortization | 0.68 | 0.45 |
| EBIT | -1.12 | -0.42 |
| EBIT Margin | -17.69% | -16.40% |
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).